NCT02006914View on ClinicalTrials.gov

Novel Therapy for Glucose Intolerance in HIV Disease

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

May 31, 2010

Study Completion Date

April 30, 2012

Conditions
Insulin Resistance
Interventions
DIETARY_SUPPLEMENT

Chromium Picolinate

Subjects will be asked to take chromium picolinate; 2 tablets per day, 1000 mcg or a placebo for a total of 8 weeks.

Trial Locations (1)

11794

Stony Brook University Hospital GCRC, Stony Brook

All Listed Sponsors
lead

Stony Brook University

OTHER

NCT02006914 - Novel Therapy for Glucose Intolerance in HIV Disease | Biotech Hunter | Biotech Hunter